|
2026
|
Invention
|
Levocetirizine and montelukast in the treatment of sepsis and symptoms thereof.
Certain embodime... |
|
2024
|
Invention
|
Levocetirizine and montelukast in the treatment of coronavirus disease and symptoms thereof.
Cer... |
|
2021
|
Invention
|
Levocetirizine and montelukast in the treatment of sepsis and symptoms thereof. Certain embodimen... |
|
2020
|
Invention
|
Levocetirizine and montelukast in the treatment of inflammation mediated conditions. The embodime... |
|
|
Invention
|
Use of levocetirizine and montelukast in the treatment of viral infection caused by coronavirus. ... |
|
2019
|
Invention
|
Use of levocetirizine and montelukast in the treatment of anaphylaxis.
The embodiments described... |
|
|
Invention
|
Use of levocetirizine and montelukast to treat rhinosinusitis and nasal polyposis.
The methods a... |
|
2018
|
Invention
|
Use of levocetirizine and montelukast in the treatment of autoimmune disorders. The embodiments d... |
|
|
Invention
|
Levocetirizine and montelukast in the treatment of radiation-mediated conditions.
Certain embodi... |
|
|
Invention
|
Use of levocetirizine and montelukast in the treatment of traumatic injury. The embodiments descr... |
|
2017
|
Invention
|
Levocetirizine and montelukast in the treatment of radiation-mediated conditions. Certain embodim... |
|
|
Invention
|
Use of levocetirizine and montelukast in the treatment of vasculitis. The embodiments described h... |
|
2015
|
Invention
|
Use of levocetirizine and montelukast to ameliorate inflammation following radiation exposure. Th... |
|
2014
|
Invention
|
Use of levocetirizine and montelukast in the treatment of anaphylaxis. The embodiments described ... |
|
2011
|
Invention
|
Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammation... |
